Inventor · disambiguated record
Martin Juhl
Also filed as: JUHL MARTIN
19 granted patents·2 pending applications·144 citations·filing 2016–2025
94Inventor score
Files withH LUNDBECK AS21
Top patents by PatentIndex Score
21 records- 0198US11707476B2Catecholamine prodrugs for use in the treatment of parkinson's diseaseH LUNDBECK AS·Filed 2021·Granted Jul 25, 2023·12 cites·17 claims
- 0298US11110110B2Catecholamine prodrugs for use in the treatment of Parkinson's diseaseH LUNDBECK AS·Filed 2020·Granted Sep 7, 2021·15 cites·20 claims
- 0398US11104697B2Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1- propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2020·Granted Aug 31, 2021·14 cites·12 claims
- 0497US12226428B2Catecholamine prodrugs for use in the treatment of Parkinson's diseaseH LUNDBECK AS·Filed 2023·Granted Feb 18, 2025·6 cites·22 claims
- 0597US11827665B2Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2021·Granted Nov 28, 2023·8 cites·21 claims
- 0697US10729710B2Catecholamine prodrugs for use in the treatment of Parkinson's diseaseH LUNDBECK AS·Filed 2018·Granted Aug 4, 2020·21 cites·15 claims
- 0796US11866410B2Process for the manufacturing of (6AR,10AR)-7-propyl-6,6A,7,8,9,10,10A,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4AR, 10AR)-1-propyl-1,2,3,4,4A,5,10,10A-octahydro-benzo[G]quinoline-6,7-diolH LUNDBECK AS·Filed 2021·Granted Jan 9, 2024·8 cites·18 claims
- 0896US11858954B2Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2021·Granted Jan 2, 2024·8 cites·31 claims
- 0996US11851456B2Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2021·Granted Dec 26, 2023·9 cites·23 claims
- 1096US11168056B2Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-G]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[G]quinoline-6,7-diolH LUNDBECK AS·Filed 2020·Granted Nov 9, 2021·14 cites·13 claims
- 1196US11130775B2Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2020·Granted Sep 28, 2021·14 cites·16 claims
- 1296US11111263B2Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2020·Granted Sep 7, 2021·15 cites·18 claims
- 1383US12479801B2Process for the manufacturing of (6aR,10aR)-7-propyl-6,6a,7,8,9,10,10a,11-octahydro-[1,3]dioxolo[4′,5′:5,6]benzo[1,2-g]quinoline and (4aR,10aR)-1-propyl-1,2,3,4,4a,5,10,10a-octahydro-benzo[g]quinoline-6,7-diolH LUNDBECK AS·Filed 2023·Granted Nov 25, 2025·0 cites·2 claims
- 1483US12421271B2Solid forms of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR, 10AR)-7-hydroxy-1-propyl-1,2,3,4,4A,5,10,10A-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2023·Granted Sep 23, 2025·0 cites·23 claims
- 1579US12398169B2Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4aR,10aR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2H-pyran-2-carboxylic acidH LUNDBECK AS·Filed 2023·Granted Aug 26, 2025·0 cites·25 claims
- 1673US2025381208A1Catecholamine prodrugs for use in the treatment of parkinson’s diseaseH LUNDBECK AS·Filed 2025·Application pending·0 cites
- 1759US12152029B2Crystalline forms of a MAGL inhibitorH LUNDBECK AS·Filed 2022·Granted Nov 26, 2024·0 cites·25 claims
- 1855US12391650B2Catecholamine prodrugs for use in the treatment of Parkinson's diseaseH LUNDBECK AS·Filed 2020·Granted Aug 19, 2025·0 cites·23 claims
- 1953US12384765B2Catecholamine prodrugs for use in the treatment of Parkinson's DiseaseH LUNDBECK AS·Filed 2020·Granted Aug 12, 2025·0 cites·27 claims
- 2051US12319710B2Catecholamine prodrugs for use in the treatment of Parkinson's diseasesH LUNDBECK AS·Filed 2020·Granted Jun 3, 2025·0 cites·29 claims
- 2139US2018319786A1Inhibitor of the p2x7 receptorH LUNDBECK AS·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Martin Juhl files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →